Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M541Revenue (TTM) $M32.8Net Margin (%)-199.6Altman Z-Score3.1
Enterprise Value $M425EPS (TTM) $-0.9Operating Margin %-208.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-200.6Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %-15.3Quick Ratio3.4Cash flow > EarningsY
Price/Sales16.25-y EBITDA Growth Rate %-5.9Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-38.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M74.1ROIC % (ttm)-296.8Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOJoel Greenblatt 2016-03-31 Sold Out $4.92 - $8.71
($6.42)
$ 7.3114%Sold Out0
INOJoel Greenblatt 2015-12-31 Buy $5.65 - $7.41
($6.67)
$ 7.3110%New holding37,123
INOFirst Eagle Investment 2014-03-31 Sold Out -0.002%$9.76 - $15.28
($11.96)
$ 7.31-39%Sold Out0
INOFirst Eagle Investment 2013-12-31 Buy $6.92 - $11.88
($8.34)
$ 7.31-12%New holding62,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sardesai NiranjanCOO 2016-08-29Sell21,800$9.3-23.76view
COLLINS MORTONDirector 2016-06-28Buy10,000$9.13-22.34view
BENITO SIMON XDirector 2016-05-18Sell6,250$10.37-31.63view
COLLINS MORTONDirector 2016-04-15Buy68,400$9.52-25.53view
Sardesai NiranjanCOO 2015-09-30Buy4,000$5.528.91view
BENITO SIMON XDirector 2015-08-14Buy6,000$7.21-1.66view
Cabrera AngelDirector 2015-04-13Buy8,000$9.53-25.6view
KIES PETERCFO 2014-10-09Buy3,960$10.1-29.8view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.01-29.17view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.74-27.21view

Press Releases about INO :

Quarterly/Annual Reports about INO:

News about INO:

Articles On GuruFocus.com
Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 

More From Other Websites
8:03 am Inovio Pharma announces that the International Vaccine Institute will provide new funding... Dec 06 2016
Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine Institute Dec 06 2016
Inovio Wins $6.1M Zika Drug Development Grant (INO) Dec 02 2016
Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based... Dec 01 2016
Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based... Dec 01 2016
Hedge Fund Sentiment Is Stagnant On Pinnacle Entertainment Inc (PNK) Nov 29 2016
Inovio Applies to Cease Reporting to Canadian Securities Regulatory Authorities; NASDAQ Listing and... Nov 25 2016
ETFs with exposure to Inovio Pharmaceuticals, Inc. : November 23, 2016 Nov 23 2016
Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016 Nov 21 2016
Inovio’s Co-Founder and Chair of its Scientific Advisory Board Selected as a Top 20 Translational... Nov 21 2016
INOVIO PHARMACEUTICALS, INC. Financials Nov 17 2016
Inovio Wins Deloitte’s “Fast 500” Growth Award Nov 16 2016
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and... Nov 14 2016
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and... Nov 14 2016
Inovio Pharmaceuticals Inc (INO) Stock: Spiking On Positive Study Results Nov 11 2016
Inovio (INO) Q3 Loss Wider than Expected, Revenues Beat Nov 10 2016
Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage and Death Nov 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)